Chemokines and Brain Functions
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
4
Page:
387-399
Author(s):
Ghazal Banisadr, William Rostene, Patrick Kitabgi and Stephane Melik Parsadaniantz
Identification of Tumor Targeting Agents by Phage Display
Journal:
Medicinal Chemistry Reviews - Online (Discontinued)
Volume:
2
Page:
219-229
Author(s):
Victor I. Romanov
Alzheimers Disease and Non-Steroidal Anti-Inflammatory Drugs: Old Therapeutic Tools with Novel Mechanisms of Action?
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
5
Page:
111-117
Author(s):
Domenico Pratico
Recent Developments in the Chemical Biology of Epothilones
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1595-1613
Author(s):
Karl Heinz Altmann
Improving the Targeting of Tubulin-Binding Agents: Lessons from Drug Resistance Studies
Journal:
Current Pharmaceutical Design
Volume:
11
Page:
1719-1733
Author(s):
N. M. Verrills and M. Kavallaris
Treatment of CNS Malignancies with a Recombinant Oncolytic Poliovirus
Journal:
Drug Design Reviews - Online (Discontinued)
Volume:
2
Page:
233-241
Author(s):
Stephanie A. Campbell, Melinda K. Merrill and Matthias Gromeier
Prospects for Plant-Derived Chemopreventive Agents Exhibiting Multiple Mechanisms of Action
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
201-213
Author(s):
L. M. Howells and M. M. Manson
Multi-Nuclear Platinum Drugs: A New Paradigm in Chemotherapy
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
5
Page:
267-279
Author(s):
Nial J. Wheate and J. Grant Collins
Regional Differences in Adaptation of CNS Mu Opioid Receptors to Chronic Opioid Agonist Administration
Journal:
Current Neuropharmacology
Volume:
3
Page:
157-182
Author(s):
L. J. Sim-Selley
Anti-Cancer / Anti-Tumor
Journal:
Current Bioactive Compounds
Volume:
1
Page:
1-24
Author(s):
Bentham Science Publishers